To investigate the clinical relevance of FBP1 in regulating c-Myc protein levels in pancreatic cancer patients, we assessed both c-Myc and FBP1 protein levels in 8 non-tumor and tumor-paired human pancreatic cancer specimens (Fig. 4e). This evidence concerns the gene MYC and pancreatic neoplasm.